Green Thumb Industries (GTBIF) Assets Average (2020 - 2026)
Green Thumb Industries' (GTBIF) quarterly Assets Average came in at $2.8 billion in Q1 2026, up 10.1% YoY from $2.6 billion in Q1 2025, and up 3.54% on a QoQ basis from $2.7 billion in Q4 2025.
Green Thumb Industries (GTBIF) Assets Average (2020 - 2026) Analysis & Trends
Green Thumb Industries (GTBIF) has 7 years of Assets Average data on file, last reported at $2.8 billion in Q1 2026.
- Quarterly Assets Average rose 10.1% year-over-year to $2.8 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 billion (up 10.1% YoY) and the FY2025 annual result came in at $2.7 billion, up 5.97% from the prior year.
- Assets Average grew to $2.8 billion in Q1 2026, from $2.7 billion in the prior quarter.
- In the past five years, Assets Average ranged from a high of $2.8 billion in Q1 2026 to a low of $2.4 billion in Q1 2022.
- A 5-year average of $2.5 billion and a median of $2.5 billion in 2024 frame the typical range for Assets Average.
- Annual changes were most pronounced in 2022 — Assets Average surged 64.49% — and 2025, when it gained 0.43%.
- Tracing GTBIF's Assets Average over 5 years: stood at $2.4 billion in 2022, then advanced by 2.04% to $2.5 billion in 2023, then climbed by 1.25% to $2.5 billion in 2024, then advanced by 7.47% to $2.7 billion in 2025, then gained by 3.54% to $2.8 billion in 2026.
- The last three Assets Average figures came in at $2.8 billion (Q1 2026), $2.7 billion (Q4 2025), and $2.6 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 5.97 Bn |
| 10 | Green Thumb Industries | 1.65 Bn | 1.37 Bn | 137.87 Mn | 2.82 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.82 Bn |
| Mar 31, 2026 | 2.81 Bn |
| Dec 31, 2025 | 2.71 Bn |
| Sep 30, 2025 | 2.59 Bn |
| Jun 30, 2025 | 2.56 Bn |
| Mar 31, 2025 | 2.55 Bn |
| Dec 31, 2024 | 2.53 Bn |
| Sep 30, 2024 | 2.53 Bn |
| Jun 30, 2024 | 2.55 Bn |
| Mar 31, 2024 | 2.52 Bn |
| Dec 31, 2023 | 2.49 Bn |
| Sep 30, 2023 | 2.51 Bn |
| Jun 30, 2023 | 2.50 Bn |
| Mar 31, 2023 | 2.46 Bn |
| Dec 31, 2022 | 2.44 Bn |
| Sep 30, 2022 | 2.45 Bn |
| Jun 30, 2022 | 2.42 Bn |
| Mar 31, 2022 | 2.39 Bn |
| Dec 31, 2021 | 2.27 Bn |
| Sep 30, 2021 | 1.97 Bn |